JP2018095584A5 - - Google Patents

Download PDF

Info

Publication number
JP2018095584A5
JP2018095584A5 JP2016240589A JP2016240589A JP2018095584A5 JP 2018095584 A5 JP2018095584 A5 JP 2018095584A5 JP 2016240589 A JP2016240589 A JP 2016240589A JP 2016240589 A JP2016240589 A JP 2016240589A JP 2018095584 A5 JP2018095584 A5 JP 2018095584A5
Authority
JP
Japan
Prior art keywords
extract
agent
organic solvent
active ingredient
scutellaria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016240589A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018095584A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2016240589A priority Critical patent/JP2018095584A/ja
Priority claimed from JP2016240589A external-priority patent/JP2018095584A/ja
Publication of JP2018095584A publication Critical patent/JP2018095584A/ja
Publication of JP2018095584A5 publication Critical patent/JP2018095584A5/ja
Pending legal-status Critical Current

Links

JP2016240589A 2016-12-12 2016-12-12 シトクロムp450−1a1の発現を阻害する薬剤 Pending JP2018095584A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2016240589A JP2018095584A (ja) 2016-12-12 2016-12-12 シトクロムp450−1a1の発現を阻害する薬剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2016240589A JP2018095584A (ja) 2016-12-12 2016-12-12 シトクロムp450−1a1の発現を阻害する薬剤

Publications (2)

Publication Number Publication Date
JP2018095584A JP2018095584A (ja) 2018-06-21
JP2018095584A5 true JP2018095584A5 (enExample) 2019-12-12

Family

ID=62631751

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016240589A Pending JP2018095584A (ja) 2016-12-12 2016-12-12 シトクロムp450−1a1の発現を阻害する薬剤

Country Status (1)

Country Link
JP (1) JP2018095584A (enExample)

Similar Documents

Publication Publication Date Title
JP2017537928A5 (enExample)
JP2017520128A5 (enExample)
JP2016065085A5 (enExample)
HRP20220075T1 (hr) Tekuća formulacija koja sadrži nikotin za aerosolnu primjenu
WO2015192127A3 (en) Formulated receptor polypeptides and related methods
EP3016653A4 (en) Pyrrolo-pyrrole carbamate and related organic compounds, pharmaceutical compositions, and medical uses thereof
JP2017137500A5 (enExample)
JP2020528637A5 (enExample)
JP2015186128A5 (enExample)
PL3445321T3 (pl) Sposoby, kompozycje i zastosowania obejmujące wybrane aldehydy podstawione grupami hydroksylowymi
LT3402782T (lt) 8-amino-2-okso-1,3-diaza-spiro-[4.5]-dekano dariniai
JP2016540019A5 (enExample)
EP3555127C0 (en) AGENTS, USES AND METHODS
EP3585351A4 (en) ECOPHILIC ANTIMICROBIAL FORMULATIONS DISRUPTING BIOFILMS, THEIR DEVELOPMENT AND THEIR USES
EP3253864A4 (en) Uses of daldinia sp. or volatile organic compounds derived therefrom
DK4023651T3 (da) Optisk aktivt pyranochromenylphenolderivat og farmaceutisk sammensætning, der omfatter samme
JP2018519528A5 (enExample)
JP2017176931A5 (enExample)
WO2018211324A8 (en) Prodrugs for the treatment of disease
JP2018150270A5 (enExample)
JP2016045189A5 (enExample)
JP2015043197A5 (enExample)
IT201800007580A1 (it) Composti 1,3,8-triazaspiro e loro uso come medicamenti
EP3634507C0 (en) ORAL EXTENDED DRUG DELIVERY PLATFORMS
EA201891848A1 (ru) Фармацевтическая композиция для применения в лечении фиброза